Sam Eiber
Stock Analyst at BTIG
(3.79)
# 2,064
Out of 4,662 analysts
63
Total ratings
61%
Success rate
12.7%
Average return
Main Sectors:
Stocks Rated by Sam Eiber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SBC SBC Medical Group Holdings | Reiterated: Buy | $8 | $3.05 | +162.30% | 3 | Aug 14, 2026 | |
| MMSI Merit Medical Systems | Reiterated: Buy | $105 | $90.87 | +15.55% | 7 | Aug 11, 2026 | |
| APYX Apyx Medical | Reiterated: Buy | $6 | $2.95 | +103.39% | 8 | Aug 7, 2026 | |
| ICUI ICU Medical | Rated: Buy | $170 → $200 | $181.83 | +9.99% | 2 | Aug 7, 2026 | |
| EOLS Evolus | Reiterated: Buy | $13 | $8.22 | +58.15% | 13 | Aug 6, 2026 | |
| ESTA Establishment Labs Holdings | Reiterated: Buy | $96 → $103 | $76.22 | +35.14% | 13 | Aug 6, 2026 | |
| STIM Neuronetics | Initiated Coverage: Buy | $5 | $3.32 | +50.60% | 1 | Jul 20, 2026 | |
| BWAY BrainsWay | Initiated Coverage: Buy | $18 | $16.76 | +7.40% | 1 | Jul 20, 2026 | |
| INMD InMode | Rated: Hold | n/a | $15.16 | - | 10 | Jul 10, 2026 | |
| AIRS AirSculpt Technologies | Maintained: Hold | n/a | $3.34 | - | 5 | May 18, 2026 |
SBC Medical Group Holdings
Aug 14, 2026
Reiterated: Buy
Price Target: $8
Current: $3.05
Upside: +162.30%
Merit Medical Systems
Aug 11, 2026
Reiterated: Buy
Price Target: $105
Current: $90.87
Upside: +15.55%
Apyx Medical
Aug 7, 2026
Reiterated: Buy
Price Target: $6
Current: $2.95
Upside: +103.39%
ICU Medical
Aug 7, 2026
Rated: Buy
Price Target: $170 → $200
Current: $181.83
Upside: +9.99%
Evolus
Aug 6, 2026
Reiterated: Buy
Price Target: $13
Current: $8.22
Upside: +58.15%
Establishment Labs Holdings
Aug 6, 2026
Reiterated: Buy
Price Target: $96 → $103
Current: $76.22
Upside: +35.14%
Neuronetics
Jul 20, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $3.32
Upside: +50.60%
BrainsWay
Jul 20, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $16.76
Upside: +7.40%
InMode
Jul 10, 2026
Rated: Hold
Price Target: n/a
Current: $15.16
Upside: -
AirSculpt Technologies
May 18, 2026
Maintained: Hold
Price Target: n/a
Current: $3.34
Upside: -